Terms: = Leukemia AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
35 results:
1. treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia.
Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim TM; Yoon SS; Park H; Kim I
Medicine (Baltimore); 2024 Feb; 103(7):e37100. PubMed ID: 38363899
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
3. Investigations of methods for multiple time-to-event endpoints: A chronic myeloid leukemia data analysis.
Wu H; Hou Y; Chen Z
J Eval Clin Pract; 2023 Feb; 29(1):211-217. PubMed ID: 35945813
[TBL] [Abstract] [Full Text] [Related]
4. Current situation of fungal diseases in Eritrea.
Werkneh S; Orefuwa E; Denning DW
Mycoses; 2022 Aug; 65(8):806-814. PubMed ID: 35633079
[TBL] [Abstract] [Full Text] [Related]
5. Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.
Rosati S; Gurnari C; Breccia M; Carmosino I; Scalzulli E; Montefusco E; Perrone S; Annibali O; Martini V; Trapè G; Colafigli G; Trawinska M; Minotti C; Cimino G; Tafuri A; Avvisati G; Martelli M; Voso MT; Latagliata R
Acta Oncol; 2021 Nov; 60(11):1520-1526. PubMed ID: 34461798
[TBL] [Abstract] [Full Text] [Related]
6. Health Care Cost Associated With Contemporary Chronic Myelogenous leukemia Therapy Compared With That of Other Hematologic Malignancies.
Wilkes JJ; Lyman GH; Doody DR; Chennupati S; Becker LK; Morin PE; Winestone LE; Henk HJ; Chow EJ
JCO Oncol Pract; 2021 Mar; 17(3):e406-e415. PubMed ID: 32822255
[TBL] [Abstract] [Full Text] [Related]
7. Secondhand smoke: A new and modifiable prognostic factor in childhood acute lymphoblastic leukemias.
Cárceles-Álvarez A; Ortega-García JA; López-Hernández FA; Fuster-Soler JL; Ramis R; Kloosterman N; Castillo L; Sánchez-Solís M; Claudio L; Ferris-Tortajada J
Environ Res; 2019 Nov; 178():108689. PubMed ID: 31479979
[TBL] [Abstract] [Full Text] [Related]
8. Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ramaekers BLT; Riemsma R; Grimm S; Fayter D; Deshpande S; Armstrong N; Witlox W; Pouwels X; Duffy S; Worthy G; Kleijnen J; Joore MA
Pharmacoeconomics; 2019 Jul; 37(7):887-894. PubMed ID: 30426463
[TBL] [Abstract] [Full Text] [Related]
9. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
10. Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
Mato AR; Nabhan C; Thompson MC; Lamanna N; Brander DM; Hill B; Howlett C; Skarbnik A; Cheson BD; Zent C; Pu J; Kiselev P; Goy A; Claxton D; Isaac K; Kennard KH; Timlin C; Landsburg D; Winter A; Nasta SD; Bachow SH; Schuster SJ; Dorsey C; Svoboda J; Barr P; Ujjani CS
Haematologica; 2018 May; 103(5):874-879. PubMed ID: 29419429
[TBL] [Abstract] [Full Text] [Related]
11. Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.
Goethe E; Carter BZ; Rao G; Pemmaraju N
J Neurooncol; 2018 Jan; 136(2):223-231. PubMed ID: 29196926
[TBL] [Abstract] [Full Text] [Related]
12. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.
Geissler J; Sharf G; Bombaci F; Daban M; De Jong J; Gavin T; Pelouchova J; Dziwinski E; Hasford J; Hoffmann VS
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1167-1176. PubMed ID: 28289895
[TBL] [Abstract] [Full Text] [Related]
13. Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Garcia-Manero G; Montalban-Bravo G; Berdeja JG; Abaza Y; Jabbour E; Essell J; Lyons RM; Ravandi F; Maris M; Heller B; DeZern AE; Babu S; Wright D; Anz B; Boccia R; Komrokji RS; Kuriakose P; Reeves J; Sekeres MA; Kantarjian HM; Ghalie R; Roboz GJ
Cancer; 2017 May; 123(6):994-1002. PubMed ID: 28094841
[TBL] [Abstract] [Full Text] [Related]
14. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
Pemmaraju N; Kantarjian H; Jorgensen JL; Jabbour E; Jain N; Thomas D; O'Brien S; Wang X; Huang X; Wang SA; Konopleva M; Konoplev S; Kadia T; Garris R; Pierce S; Garcia-Manero G; Cortes J; Ravandi F
Am J Hematol; 2017 Mar; 92(3):279-285. PubMed ID: 28052371
[TBL] [Abstract] [Full Text] [Related]
15. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract] [Full Text] [Related]
16. Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of atrx and DAXX.
Hu Y; Shi G; Zhang L; Li F; Jiang Y; Jiang S; Ma W; Zhao Y; Songyang Z; Huang J
Sci Rep; 2016 Aug; 6():32280. PubMed ID: 27578458
[TBL] [Abstract] [Full Text] [Related]
17. [Everolimus combined with all-trans retinoid acid reverses drug resistance in acute promyelocytic leukemia NB4-R1 cells].
Liao WC; He Y; Wang BS; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 44(5):525-31. PubMed ID: 26713527
[TBL] [Abstract] [Full Text] [Related]
18. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
[TBL] [Abstract] [Full Text] [Related]
19. Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research database.
Stenehjem DD; Albright F; Kuo KL; Raimundo K; Bauer H; Shami PJ; Deininger MW; Chen L; Brixner DI
J Natl Compr Canc Netw; 2014 Aug; 12(8):1113-21. PubMed ID: 25099443
[TBL] [Abstract] [Full Text] [Related]
20. Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.
Goldberg A; Geppert T; Schiopu E; Frech T; Hsu V; Simms RW; Peng SL; Yao Y; Elgeioushi N; Chang L; Wang B; Yoo S
Arthritis Res Ther; 2014 Feb; 16(1):R57. PubMed ID: 24559157
[TBL] [Abstract] [Full Text] [Related]
[Next]
